Richard R. DeLuca, EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. (MRK), sold 59,564 shares at $90.40 ($5.4M) on 2021-11-04, disclosed to the SEC on 2021-11-05.
Open-market sale of $5.4M MRK by EVP&Pres, Merck Animal Heallth. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.40 | 29,782 | $2.7M | 50.0% |
| 2 | $90.40 | 29,782 | $2.7M | 50.0% |
| Total | $90.40 avg | 59,564 | $5.4M | 100% |
| Filing → |
| MRK | SELL | 2026-02-06 | $4.6M | — | Filing → |
| MRK | SELL | 2023-11-09 | $9.2M | — | Filing → |
| MRK | SELL | 2023-05-02 | $25.1M | — | Filing → |